SLCO2B1 and SLCO1B3 may determine time to progression for patients receiving androgen deprivation therapy for prostate cancer (Q35112055)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
SLCO2B1 and SLCO1B3 may determine time to progression for patients receiving androgen deprivation therapy for prostate cancer
scientific article

    Statements

    SLCO2B1 and SLCO1B3 may determine time to progression for patients receiving androgen deprivation therapy for prostate cancer (English)
    Wanling Xie
    Elahe Mostaghel
    Lillian Werner
    Mark Pomerantz
    Matthew Freedman
    Robert Ross
    Meredith Regan
    Nima Sharifi
    William Douglas Figg
    Steven Balk
    Gwo-Shu Mary Lee
    2565-2573

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit